S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.37%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
GILD   74.76 (-1.54%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.37%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
GILD   74.76 (-1.54%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.37%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
GILD   74.76 (-1.54%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.37%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
GILD   74.76 (-1.54%)
DIS   96.60 (-3.21%)
Log in

NYSE:MCK - McKesson Stock Price, Forecast & News

$135.26
-2.76 (-2.00 %)
(As of 03/31/2020 04:00 PM ET)
Today's Range
$132.33
Now: $135.26
$138.63
50-Day Range
$115.75
MA: $146.23
$170.96
52-Week Range
$111.71
Now: $135.26
$172.18
Volume3.10 million shs
Average Volume10.42 million shs
Market Capitalization$23.93 billion
P/E RatioN/A
Dividend Yield1.30%
Beta1.03
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Read More
McKesson logo

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
CUSIP58155Q10
Phone972-446-4800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$214.32 billion
Cash Flow$31.98 per share
Book Value$43.20 per share

Profitability

Net Income$34 million

Miscellaneous

Employees80,000
Market Cap$23.93 billion
Next Earnings Date5/13/2020 (Estimated)
OptionableOptionable

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.


McKesson (NYSE:MCK) Frequently Asked Questions

How has McKesson's stock been impacted by COVID-19 (Coronavirus)?

McKesson's stock was trading at $135.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MCK shares have increased by 0.1% and is now trading at $135.26. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of McKesson?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 1 sell rating, 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for McKesson.

When is McKesson's next earnings date?

McKesson is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for McKesson.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) released its earnings results on Tuesday, February, 4th. The company reported $3.81 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $3.56 by $0.25. The firm had revenue of $59.17 billion for the quarter, compared to analysts' expectations of $59.10 billion. McKesson had a negative net margin of 0.41% and a positive return on equity of 36.40%. The firm's revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the firm posted $3.40 EPS. View McKesson's earnings history.

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson declared a quarterly dividend on Wednesday, January 29th. Investors of record on Monday, March 2nd will be given a dividend of $0.41 per share on Wednesday, April 1st. This represents a $1.64 dividend on an annualized basis and a yield of 1.21%. The ex-dividend date is Friday, February 28th. View McKesson's dividend history.

What guidance has McKesson issued on next quarter's earnings?

McKesson issued an update on its FY20 earnings guidance on Tuesday, March, 17th. The company provided earnings per share guidance of $14.67-14.87 for the period, compared to the Thomson Reuters consensus estimate of $14.74.

What price target have analysts set for MCK?

12 brokerages have issued 1-year target prices for McKesson's stock. Their forecasts range from $140.00 to $197.00. On average, they anticipate McKesson's share price to reach $162.55 in the next twelve months. This suggests a possible upside of 20.2% from the stock's current price. View analysts' price targets for McKesson.

Has McKesson been receiving favorable news coverage?

News articles about MCK stock have been trending somewhat negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. McKesson earned a daily sentiment score of -1.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutMcKesson.

Are investors shorting McKesson?

McKesson saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 36,482,200 shares, an increase of 93.4% from the February 27th total of 18,860,000 shares. Based on an average daily trading volume, of 3,930,000 shares, the short-interest ratio is presently 9.3 days. Currently, 25.6% of the shares of the stock are sold short. View McKesson's Current Options Chain.

Who are some of McKesson's key competitors?

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Gilead Sciences (GILD), salesforce.com (CRM), CVS Health (CVS), Allergan (AGN), UnitedHealth Group (UNH), Bank of America (BAC), AbbVie (ABBV), Chevron (CVX) and Intel (INTC).

Who are McKesson's key executives?

McKesson's management team includes the following people:
  • Mr. John H. Hammergren, Chairman & CEO (Age 60)
  • Britt J. Vitalone, CFO & Exec. VP (Age 50)
  • Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
  • Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
  • Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $135.26.

How big of a company is McKesson?

McKesson has a market capitalization of $23.93 billion and generates $214.32 billion in revenue each year. The company earns $34 million in net income (profit) each year or $13.57 on an earnings per share basis. McKesson employs 80,000 workers across the globe. View additional information about McKesson.

What is McKesson's official website?

The official website for McKesson is http://www.mckesson.com/.

How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]


MarketBeat Community Rating for McKesson (NYSE MCK)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  856 (Vote Outperform)
Underperform Votes:  524 (Vote Underperform)
Total Votes:  1,380
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel